Markus Talanow

• Education
• Germany
• Pharma & Biotech
• Science
• Technology

Merck announced the enrollment of first patient into new Phase III study in the area of fertility

• The ESPART* Phase III clinical study focuses on patients that respond poorly to attempts at ovarian stimulation • Study…